Discrimination between defects in elongation fidelity and termination efficiency provides mechanistic insights into translational readthrough.
The suppression of stop codons (termed translational readthrough) can be caused by a decreased accuracy of translation elongation or a reduced efficiency of translation termination. In previous studies, the inability to determine the extent to which each of these distinct processes contributes to a readthrough phenotype has limited our ability to evaluate how defects in the translational machinery influence the overall termination process. Here, we describe the combined use of misincorporation and readthrough reporter systems to determine which of these mechanisms contributes to translational readthrough in Saccharomyces cerevisiae. The misincorporation reporter system was generated by introducing a series of near-cognate mutations into functionally important residues in the firefly luciferase gene. These constructs allowed us to monitor the incidence of elongation errors by monitoring the level of firefly luciferase activity from a mutant allele inactivated by a single missense mutation. In this system, an increase in luciferase activity should reflect an increased level of misincorporation of the wild-type amino acid that provides an estimate of the overall fidelity of translation elongation. Surprisingly, we found that growth in the presence of paromomycin stimulated luciferase activity for only a small subset of the mutant proteins examined. This suggests that the ability of this aminoglycoside to induce elongation errors is limited to a subset of near-cognate mismatches. We also found that a similar bias in near-cognate misreading could be induced by the expression of a mutant form of ribosomal protein (r-protein) S9B or by depletion of r-protein L12. We used this misincorporation reporter in conjunction with a readthrough reporter system to show that alterations at different regions of the ribosome influence elongation fidelity and termination efficiency to different extents.
Salas-Marco
Joe
J
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294-2170, USA.
Bedwell
David M
DM
D001224:Aspartic Acid / Q000235:genetics / Q000378:metabolism; D001483:Base Sequence; D018388:Codon, Terminator / Q000235:genetics; D015966:Gene Expression Regulation, Fungal / Q000187:drug effects; D017930:Genes, Reporter / Q000235:genetics; D049409:Luciferases, Firefly / Q000235:genetics / Q000378:metabolism; D016296:Mutagenesis / Q000187:drug effects; D009154:Mutation / Q000235:genetics; D010303:Paromomycin / Q000494:pharmacology; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects; D010443:Peptide Chain Termination, Translational / Q000187:drug effects; D010641:Phenotype; D020365:RNA Helicases / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D012343:RNA, Transfer / Q000235:genetics; D012269:Ribosomal Proteins / Q000172:deficiency / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000201:enzymology / Q000235:genetics*; D029701:Saccharomyces cerevisiae Proteins
D018388:Codon, Terminator; D012269:Ribosomal Proteins; D029701:Saccharomyces cerevisiae Proteins; D001224:Aspartic Acid; D010303:Paromomycin; C016700:ribosomal protein L7-L12; D012343:RNA, Transfer; D049409:Luciferases, Firefly; C074151:NAM7 protein, S cerevisiae; D020365:RNA Helicases